Synthesis of macrocyclic lactams from 2-(ω-amino-alkyl)-2-benzoylamino-3-phenyl-N,N-dimethylpropan-amides via direct amide cyclization

Article abstract of DOI:10.3987/COM-08-S(D)76

The alkylation of 4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (11) with (ω-azidoalkyl iodides (12) by deprotonation with LDA in THF/HMPT at -78 °C yielded mixtures of the 4,4-disubstituted l,3-oxazol-5(4H)-ones (13) and the O-alkylated 1,3-oxazoles (14) in 65-

Full text of DOI:10.3987/COM-08-S(D)76

HETEROCYCLES, Vol. 79, 2009
985
HETEROCYCLES, Vol. 79, 2009, pp. 985 - 1005. © The Japan Institute of Heterocyclic Chemistry
Received, 30th October, 2008, Accepted, 15th December, 2008, Published online, 16th December, 2008.
DOI: 10.3987/COM-08-S(D)76
SYNTHESIS OF MACROCYCLIC LACTAMS FROM 2-(ω-AMINO-
ALKYL)-2-BENZOYLAMINO-3-PHENYL-N,N-DIMETHYLPROPAN-
AMIDES VIA DIRECT AMIDE CYCLIZATION
Stephan P. Fritschi,1 Anthony Linden, and Heinz Heimgartner*
Institute of Organic Chemistry, University of Zürich, Winterthurerstrasse 190,
CH-8057-Zürich, Switzerland; E-mail: heimgart@oci.uzh.ch
Dedicated to the memory of Dr. John Daly
Abstract – The alkylation of 4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (11) with
ω-azidoalkyl iodides (12) by deprotonation with LDA in THF/HMPT at –78 °C
yielded mixtures of the 4,4-disubstituted 1,3-oxazol-5(4H)-ones (13) and the
O-alkylated 1,3-oxazoles (14) in 65–50%, with 13 as the major product. The
reaction of the latter with dimethylamine in acetonitrile at room temperature led to
ω-azido-2-benzamido-2-benzylalkane amides (15), which were reduced to give
the corresponding ω-amino derivatives (16). On treatment with HCl gas or BF3 in
boiling toluene, the macrocyclic 2-benzamido lactams (18) were formed in up to
27% yield via the intermediate formation of 1,3-oxazol-5(4H)-ones (17). The
structures of the 14- and 15-membered lactams have been established by X-ray
crystallography.
INTRODUCTION
In the last couple of years, we have investigated extensively the use of 2,2-disubstituted
2H-azirin-3-amines (1) as synthons for α,α-disubstituted α-amino acids in peptide synthesis.2–16 The basic
concept is the so-called ‘azirine/oxazolone method’,17–22 in which both the selective hydrolysis of the
terminal amide group of 2, obtained via extension of the peptide chain by the reaction with the
2H-azirin-3-amine (1), to give 4, and the coupling with the next amino acid or peptide segment to yield 5
occur via 1,3-oxazol-5(4H)-ones (azlactones, 3) as intermediates (Scheme 1, see also refs.23,24). In a very
recent study, Brückner and coworkers pointed to the high tendency of peptides containing
α-aminoisobutyric acid (Aib) to undergo acid-catalyzed cleavage of the peptide chain via the formation of
1,3-oxazol-5(4H)-ones.25

986
HETEROCYCLES, Vol. 79, 2009
Scheme 1
R1
O
R1
R3
R2
H
N
CH2Cl2
N(Me)Ph
R
R
+
N
H
N(Me)Ph
N
H
COOH
rt
R2
R3
N
O
1
2
+
- Ph(Me)NH2 Cl-
R1
HCl
H
R
N
COOH
R3
N
H
R2
H2O
R2
O
R3
coupling
reagent
N
4
H
N
R
O
O
R1
R1
O
R4
H
N
R4
OR5
3
R
N
H
N
H
OR5
R2
R3
H2N
O
O
O
5
Furthermore, it has been shown that the cyclization of peptide-like compounds of type (6) by treatment
with dry HCl gas in toluene at 100 °C proceeds smoothly (‘direct amide cyclization’), and cyclic
depsipeptides (7) are formed in astonishingly high yield (Scheme 2).9,26–30 Again, the ‘activated
intermediates’ are 1,3-oxazol-5(4H)-ones, which are formed via acid-catalyzed cyclization of the
C-terminal acyl-Aib-NMe2 unit.
Scheme 2
H
N
HN
O
O
O
O
HCl gas
Ph
O
H
N
H
N
O
O
NH
HO
N
H
N
H
NMe2
H
N
toluene
100 °C
- Me2NH2+Cl-
O
Ph
O
O
O
7 (48%, ref.28)
6
Under different reaction conditions, i.e., by the treatment of penta to octapeptides containing
α,α-disubstituted glycines and deprotected H2N– and –COOH termini with peptide coupling reagents, the
synthesis of the corresponding cyclopeptides could be achieved.3,12–14,31 Also in these cases,
1,3-oxazol-5(4H)-ones are likely intermediates in the cyclization reaction.

HETEROCYCLES, Vol. 79, 2009
987
The above ring closing reactions to cyclodepsipeptides and cyclopeptides can be characterized by the
sequence 8 → 9 (Scheme 3), in which the nucleophilic group in the side chain at C(2) of the
1,3-oxazol-5(4H)-one (8, R3 = HNu~~) attacks C(5) of 8, followed by ring opening. The intermolecular
version of this reaction, e.g., the ring opening of 1,3-oxazol-5(4H)-ones via hydrolysis and methanolysis,
is well known32–36 (for some relevant examples, see refs.37–41). The preferred reaction mechanism is the
nucleophilic attack at C(5), but, depending on steric and electronic effects of the substitutens, the
nucleophilic attack of H2O can also occur at C(2), leading to the same product.42,43 Similarly, the reactions
of 1,3-oxazol-5(4H)-ones with N-nucleophiles lead to α-(N-acylamino) alkanamides or peptides via
attack at C(5).43–45
Scheme 3
R1
O
R2
H
N
H
N
R2
R1
R2
O
R3
N
H+
H+
R3
O
O
Nu
Nu
O
R3 =
R1 =
O
NuH
NuH
8
10
9
Some years ago, we demonstrated that 1,3-oxazol-5(4H)-ones with an OH group in the side chain at C(4),
i.e., 8, R1 = HO~~, under acidic conditions (HCl, toluene, 110 °C) form 2-acylaminolactones via the
nucleophilic addition to the C(5)=O group of the azlactone, followed by ring opening31,46 (8 → 10,
Scheme 3).
In the present paper, the results of lactam formations of the type 8 → 10 (HNu = NH2) under acidic
conditions (‘direct amide cyclization’) are reported.
RESULTS AND DISCUSSION
We intended to prepare 1,3-oxazol-5(4H)-ones of type (13) with an NH2 group in the side chain as
starting materials for the cyclization of type 8 → 10 via the alkylation of the anion of
4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (11)47,48 (Scheme 4). Whereas benzylations and allylations of
azlactones are known to proceed smoothly by using Hünig’s base,41,49,50 alkylations occur more sluggishly.
These reactions could be improved by variation of the reaction conditions, e.g., the base and the
solvent.38,45,46,51,52 For this reason, alkyl iodides are the most promising reagents. The required alkyl
iodides (12) with N3 as a masked amino group were prepared in a straightforward sequence starting with
ω-bromoalkanols, which were transformed into the corresponding ω-azidoalkanols, respectively. These
products were treated with 2-fluoro-N-methylpyridinium tosylate (FMPT) and NaI53 to give the desired
ω-azidoalkyliodides (12a–c) in good yields (see experimental part).

988
HETEROCYCLES, Vol. 79, 2009
Scheme 4
Ph
Ph
Ph
1. LDA, THF/HMPT
-78 °C
(CH2)n N3
N
N
N
+
Ph
O
Ph
O
(CH2)n N3
Ph
O
2.
I
(CH2)n N3
O
O
O
12
-78 °C to 15 °C
11
14
13
Me2NH
MeCN, rt
Ph
Ph
O
O
(CH2)n N3
NMe2
(CH2)n NH2
NMe2
Et3P, H2O
THF, rt
Ph
N
H
Ph
N
H
O
O
15
16
The alkylations of 11 were carried out in a mixture of THF/HMPT by deprotonation with LDA at ca.
–78 °C and reaction with 12a–c at ca. 15 °C. In all cases, mixtures of the 4-alkylated oxazolones (13) and
the O-alkylated oxazoles (14) were obtained with 13 as the major product (Table 1). All attempts to
separate the two products were in vain.
Table 1. Alkylation of 4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (11)a)
n
Alkyl iodide (12)
Products 13 + 14 [%]
Ratio 13/14
37 : 23
19 : 1
15 [%] 16 [%]
12
11
10
a
b
c
50
65
61
96
94
91
95
quant.
97
10 : 1
a) Reaction conditions: i) addition of LDA to a solution of 11 in THF/HMPT at –78 °C; ii) addition
of the iodide (12) at –78 °C; iii) increasing the temperature to 15 °C.
Furthermore, preliminary experiments (H2, Pd/C; LiAlH4; ZnCl2 or SnCl2 in MeOH) showed that it was
not possible to reduce the azido group of 13 without destroying the azlactone structure. Therefore, the
mixtures 13/14 were treated with dimethylamine in acetonitrile to yield the azido amides (15), which

HETEROCYCLES, Vol. 79, 2009
989
subsequently were reduced in a Staudinger reaction54–56 with triethylphosphine57 and water to give the
corresponding amines (16) in almost quantitative yields.58
The ω-aminoalkyl-substituted diamides (16) were exposed to the conditions of the ‘direct amide
cyclization’,46 i.e., dry HCl gas was bubbled through a solution of 16 in boiling dry toluene for 1.5–2 h,
and the mixture was kept boiling for 15 h. Then, toluene and excess HCl were evaporated and the residue
was separated by ‘flash column chromatography’59 (SiO2, Et2O/hexane) to give the lactams 18a–c in 27,
23, and 11% yield, respectively (Scheme 5). In an analogous experiment with 16c, in which toluene had
not been dried before its use, the corresponding carboxylic acid (19c) was obtained in 51% yield,
indicating the intermediate formation of an oxazolonium ion of type (17).
Scheme 5
Ph
N
Ph
Ph
H
H
N
O
(CH2)n NH2
NMe2
(CH2)n NH2
Ph
(CH2)n
HCl gas
Ph
N
H
Ph
O
O
O
- HCl
N
H
toluene
reflux
-Me2NH2+Cl-
O
O
Cl
16a-c
17a-c.HCl
18a-c
a: n = 12; b: n = 11; c: n = 10
Ph
Ph
Ph
Ph
Ph
NH
NH
NH
Ph
NH
NH
NH
O
O
O
O
O
O
18a
18c
18b
Ph
O
(CH2)10 NH2
COOH
Ph
N
H
19c
The spectroscopic data (MS, NMR, IR) of 18a–c were in accordance with the lactam structures.
Indicative were two IR absorptions at 1675–1670 and 1650–1645 cm–1; the amide bands in the precursors
1
(16) appeared at 1660 and 1625 cm–1. The H-NMR spectra showed the lactam NH (CONH–CH2) at
5.80–5.30 ppm as a multiplet or broadened signal, whereas the NH of the benzamide group absorbed as a

990
HETEROCYCLES, Vol. 79, 2009
singlet at 7.64–7.61 ppm. The corresponding absorptions in 16 were at ca. 1.95 (NH2) and 7.99 ppm
13
(PhCONH). On the other hand, the differences of the C-NMR absorptions for the amide and lactam
C=O groups of 18 were not significant.
For this reason, the structures of 18a and 18b were established by X-ray crystal-structure determinations
(Figure 1). Suitable crystals were grown from Et2O/hexane/CH2Cl2 and CH2Cl2/hexane, respectively,
whereas no good crystals of 18c could be obtained.
a)
b)
Figure 1. ORTEP plots60 of the molecular structures of a) 18a and b) 18b (arbitrary numbering of the
atoms; 50% probability ellipsoids)
Since the space groups of 18a and 18b are centrosymmetric, the compounds in the crystal are racemic.
The macrocyclic ring of 18a is severely disordered. The disorder is of the type common to such rings
where the molecule can adopt a large number of slightly different conformations. The net effect is that the
electron density of each atom is spread out over a wide region and it is very difficult to define a model,
which closely fits the electron density. Two sets of positions were defined for seven consecutive CH2
groups. Furthermore, the crystals were very weakly diffracting, and only a small percentage of the
reflections in the region with 2θ > 40° had a measurable intensity. It was also necessary to record the data
at room temperature, because the crystals were always damaged when the temperature was reduced.
These factors, together with the disorder, have resulted in a poor agreement between the model and the

HETEROCYCLES, Vol. 79, 2009
991
observed data. This is reflected in the high R-factor and large estimated standard deviations for the atomic
parameters. The model is the best one obtainable under the circumstances, but the nature of the disorder
makes it extremely difficult to adequately account for the electron density distribution in the disordered
region of the molecule. The refined model is therefore only an approximation to the large number of
actual molecular conformations adopted in the crystal lattice. In the case of 18b, the macrocyclic ring is
disordered over two conformations. Two sets of positions were defined for five consecutive CH2 groups.
The N-H group of the 15- and 14-membered rings (in 18a and 18b, resp.) acts as a donor for
intermolecular hydrogen bonds with the corresponding acceptor atom being the carbonyl O-atom of the
side chain of a neighboring molecule. These interactions link the molecules into extended chains which
run parallel to the [010] direction and can be described by a graph set motif61 of C(7). The NH of the
benzamide group is not involved in any intermolecular hydrogen bonds.
A possible explanation for the low yields of the cyclization reaction in comparison with analogous
lactone formations46 is the unfavorable strongly acidic reaction condition, which led to the preferred
protonation of the amino group, and not only to that of the amide group in 16 or the intermediate
oxazolone to give the activated 17.62 Therefore, we tried to substitute the Brønsted acid by a Lewis acid,
e.g., boron trifluoride (BF3).
Treatment of a solution of 16a and 16c in toluene with BF3.Et2O at 100 °C and chromatographic workup
led to the corresponding lactams (18a) and (18c), respectively, in only 7–8% yield. In addition, a labile
product, for which we propose the structure 20a,c, was obtained in 10 and 23% yield, respectively
(Scheme 6). In the case of 20c, it was possible to collect the spectroscopic data (see experimental part),
which supported the structure, but the compound was not stable at room temperature and decomposed
slowly to give at least three different products. The isolated homologous product (20a) rearranged within
a few minutes into the azlactone (17a), which had also been isolated in 30% yield from the original
reaction mixture. Furthermore, the linear ω-benzamido α-amino acid (21a) was obtained in 35% yield.
In an additional experiment, a solution of 16a and BF3.Et2O in toluene was heated to reflux for 2 h. Then,
6 equivalents of methanol were added and the mixture was kept boiling for another 21 h.
Chromatographic workup gave the ester (22a) in 80% yield, and a second product in ca. 6% yield, which
rearranged quickly to give 22a.
A likely reaction mechanism for the formation of 21a and 22a is shown in Scheme 6. Whereas, in the
intermediate azlactones (17), the nucleophilic addition of the NH2 group onto the C(5)=O group leads to
the lactams (18), the alternative addition onto C(2)42,43 yields the bicyclic product (20). Hydrolysis and
methanolysis of 20a then give the linear α-amino-ω-benzamido alkanoic acid (21) and ester (22),
respectively.

992
HETEROCYCLES, Vol. 79, 2009
Scheme 6
Ph
Ph
O
(CH2)n NH2
NMe2
(CH2)n NH2
O
N
BF3•OEt2
BF3•OEt2
Ph
N
H
18a,c
Ph
O
toluene
100 °C
O
+
-Me2NH2 Cl-
16a,c
17a,c
a: n = 12; c: n = 10
H
N
O
Ph
O
(CH2)n
COOR
NH2
(CH2)n
Ph
N
H
H2O or MeOH
O
N
H
Ph
Ph
20a,c
21a R = H
22a R = Me
CONCLUSIONS
The α,α-disubstituted α-acylamino acid amides of type (16), which bear an amino group in the
ω-position, are conveniently accessible via alkylation of 4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (11)
with ω-azidoalkyl iodides (12), ring opening with dimethylamine, and reduction of the azido group.
Treatment of 16 with dry HCl gas in boiling toluene leads to the corresponding α-benzamido lactams (18),
albeit in low yield. The analogous BF3-catalyzed cyclization yields a mixture of different products with
the lactams (18) in very low yield. We propose that the cyclization reactions occur via the intermediate
formation of 1,3-oxazol-5(4H)-ones (azlactones, 17), i.e., the so-called ‘direct amide cyclization’. An
indication for the appearance of azlactones as intermediates is the formation of the products (19) – (22),
and in the BF3-catalyzed reaction with 16a, the corresponding azlactone 17a could be isolated.
EXPERIMENTAL
General remarks. TLC: silica gel 60 F254 aluminium sheets (0.25 mm, Merck). Flash column
chromatography59 (FCC): silica gel 60 (40–60 µm, Merck). Melting points: Mettler FP-5 apparatus,
uncorrected. IR spectra: Perkin-Elmer 297 or Perkin-Elmer 781 IR spectrophotometer, in CHCl3 or KBr;
1
13
in cm–1. H-NMR (300 MHz) and C-NMR (50 MHz) spectra: Varian XL-200, Bruker AC-300, and
Bruker ARX-300 instrument, in DMSO-d6 or CDCl3; chemical shifts in ppm, coupling constants J in Hz;
multiplicity of C atoms from DEPT spectra. EI-MS: MAT-112 instrument, 70 eV; CI-MS: MAT-90
instrument, isobutane or NH3 as carrier gas; ESI-MS: Finnigan TSQ-700 instrument.

HETEROCYCLES, Vol. 79, 2009
993
Starting
materials.
4-Benzyl-2-phenyl-1,3-oxazol-5(4H)-one
(11)
was
prepared
from
2-benzamido-3-phenylpropanoic acid according to ref.47 All other reagents and solvents were
commercially available (Fluka, Aldrich).
Synthesis of ω-azidoalkan-1-ols. General procedure. A solution of a ω-bromoalkan-1-ol (1 equiv.), NaN3
(2 equiv.), and Bu4NHSO4 (0.1 equiv.) in THF/H2O (2:1) was stirred for 60 h at 25–34 °C. Then, the
mixture was poured into H2O and extracted with Et2O (3x). The organic phase was dried over MgSO4,
filtered, and evaporated. The crude products were directly used for the next reaction.
12-Azidododecan-1-ol. From 12-bromododecan-1-ol (3.03 g, 11.4 mmol) in THF (13 mL) and H2O (7
mL), NaN3 (1.49 g, 22.9 mmol), and Bu4NHSO4 (0.78 g, 2.3 mmol). Yield: 2.52 g (97%). Colorless oil.
IR (CHCl3): 3620w, 3450w (br), 3000w, 2930s, 2860s, 2100s, 1470m, 1460m, 1390w, 1350w, 1290m,
1
1255m (br), 1050m (br), 1015w, 890w (br). H-NMR (CDCl3): 3.64 (t-like, J ≈ 5.2, CH2O); 3.25 (t, J =
13
6.9, CH2N3); 1.65–1.50 (m, 3 CH2); 1.45–1.25 (m, 7 CH2). C-NMR (CDCl3): 62.8 (t, CH2O); 51.4 (t,
CH2N3); 32.7, 29.5 (2t, 2 CH2); 29.4, 29.3 (2t, 4 CH2); 29.0, 28.7, 26.6, 25.6 (4t, 4 CH2). CI-MS (NH3):
245 (28, [M+18]+), 228 (7, [M+1]+), 200 (100, [M+1–N2]+).
11-Azidoundecan-1-ol. From 11-bromoundecan-1-ol (3.98 g, 15.8 mmol) in THF (20 mL) and H2O (10
mL), NaN3 (1.23 g, 19.0 mmol), and Bu4NHSO4 (0.97 g, 2.9 mmol). Yield: 3.37 g (quant.). Colorless oil.
IR (CHCl3): 3620m, 3460w (br), 3030w, 3010m, 2930s, 2860s, 2100s, 1465m, 1455m, 1390w, 1350m,
1
1285m, 1250m (br), 1110w, 1050m (br), 1025m, 890w (br). H-NMR (CDCl3): 3.65 (t, J = 6.6, CH2O);
3.26 (t, J = 6.9, CH2N3); 1.65–1.50 (m, 2 CH2); 1.40–1.25 (m, 7 CH2). 13C-NMR (CDCl3): 62.5 (t, CH2O);
51.3 (t, CH2N3); 32.5, 29.4 (2t, 2 CH2); 29.2 (t, 3 CH2); 28.9, 28.6, 26.5, 25.6 (4t, 4 CH2). CI-MS (NH3):
214 (6, [M+1]+), 186 (100, [M+1–N2]+). Anal. Calcd for C11H23N3O: C, 61.93; H, 10.87; N, 19.70. Found:
C, 61.69; H, 10.66; N, 19.86.
10-Azidodecan-1-ol. From 10-bromodecan-1-ol (1.90 g, 8.0 mmol) in THF (10 mL) and H2O (5 mL),
NaN3 (0.63 g, 9.6 mmol), and Bu4NHSO4 (0.49 g, 1.4 mmol). Yield: 1.58 g (99%). Colorless oil. IR
(CHCl3): 3620w, 3440w (br), 3030w, 2995w, 2920s, 2850s, 2095s, 1465s, 1455w, 1390w, 1350w, 1300m,
1
1255m (br), 1045m (br), 1015w, 915w. H-NMR (CDCl3): 3.65 (t, J = 6.6, CH2O); 3.26 (t, J = 6.9,
CH2N3); 1.70–1.50 (m, 2 CH2); 1.50–1.20 (m, 6 CH2). 13C-NMR (CDCl3): 62.8 (t, CH2O); 51.4 (t, CH2N3);
32.6, 29.4 (2t, 2 CH2); 29.3 (t, 2 CH2); 29.0, 28.7, 26.6, 25.6 (4t, 4 CH2). CI-MS (NH3): 217 (100,
[M+18]+), 200 (9, [M+1]+), 172 (48, [M+1–N2]+). Anal. Calcd for C10H21N3O: C, 60.27; H, 10.62; N,
21.08. Found: C, 60.37; H, 10.45; N, 20.98.
Synthesis of ω-azidoalkyl iodides (12). General procedure. To a solution of an ω-azidoalkan-1-ol (1
equiv.) and triethylamine (TEA, 1.5 equiv.) in CHCl3 was added 2-fluoro-N-methylpyridinium tosylate

994
HETEROCYCLES, Vol. 79, 2009
(FMPT, 1.5–2.0 equiv.) and the mixture stirred for 2 h at 24 °C. After evaporation of the solvent, the
residue was dissolved in acetone, NaI (2 equiv.) was added, and the mixture was heated to reflux for 18 h.
The precipitate was filtered, the filtrate evaporated, and Et2O added. Filtration, evaporation, and FCC
(SiO2, Et2O/hexane 1:9 to 2:1) gave the product and up to 50% recovered starting material.
12-Azidododecyl iodide (12a). From 12-azidododecan-1-ol (2.30 g, 10.1 mmol) in CHCl3 (55 mL), FMPT
(4.29 g, 15.1 mmol), and TEA (1.54 g, 15.2 mmol), and then NaI (3.03 g, 20.2 mmol) in acetone (55 mL).
Yield: 1.68 g (49%) of 12a. Colorless oil. IR (CHCl3): 3000w, 2930s, 2860s, 2100s, 1465w, 1460w,
1
1370w, 1350w, 1290w, 1255w (br), 1170w (br). H-NMR (CDCl3): 3.19 (t, J = 6.9, CH2N3); 3.12 (t, J =
7.1, CH2I); 1.75 (p, J ≈ 7.1, CH2); 1.65–1.45 (m, CH2); 1.40–1.15 (m, 8 CH2). 13C-NMR (CDCl3): 51.4 (t,
CH2N3); 33.5, 30.4 (2t, 2 CH2); 29.4 (t, 3 CH2); 29.3, 29.1, 28.8, 28.4, 26.6 (5t, 5 CH2); 7.1 (t, CH2I).
CI-MS (NH3): 310 (14, [M+1–N2]+), 182 (19), 151 (100). Anal. Calcd for C12H24IN3: C, 42.74; H, 7.17; I,
37.63; N, 12.46. Found: C, 42.53; H, 7.02; I, 37.41, N, 12.38.
11-Azidoundecyl iodide (12b). From 11-azidoundecan-1-ol (2.21 g, 10.4 mmol) in CHCl3 (55 mL), FMPT
(4.29 g, 15.1 mmol), and TEA (1.60 g, 15.8 mmol), and then NaI (3.03 g, 20.2 mmol) in acetone (50 mL).
Yield: 1.78 g (53%) of 12b. Colorless oil. IR (CHCl3): 3000w, 2930s, 2860m, 2100s, 1465w, 1455w,
1
1370w, 1350w, 1255w (br), 1170w. H-NMR (CDCl3): 3.26 (t, J = 7.0, CH2N3); 3.19 (t, J = 7.0, CH2I);
1.82 (p, J ≈ 7.2, CH2); 1.60 (p, J ≈ 7.3, CH2); 1.45–1.25 (m, 7 CH2). 13C-NMR (CDCl3): 51.4 (t, CH2N3);
33.5, 30.4 (2t, 2 CH2); 29.30 (t, 2 CH2); 29.27, 29.0, 28.8, 28.4, 26.6 (5t, 5 CH2); 7.1 (t, CH2I). CI-MS
(NH3): 324 (14, [M+1]+), 296 (100, [M+1–N2]+). Anal. Calcd for C11H22IN3: C, 40.88; H, 6.86; I, 13.00; N,
39.26. Found: C, 40.86; H, 6.61; I, 12.82; N, 39.05.
10-Azidodecyl iodide (12c). From 10-azidodecan-1-ol (1.45 g, 7.3 mmol) in CHCl3 (35 mL), FMPT (4.22
g, 14.6 mmol), and TEA (1.52 g, 10.9 mmol), and then NaI (2.18 g, 14.6 mmol) in acetone (50 mL).
Yield: 1.11 g (49%). Colorless oil. IR (CHCl3): 3000m, 2930s, 2860s, 2100s, 1465m, 1455m, 1430w,
1370w, 1350m, 1295m, 1285m, 1260m (br), 1175m, 1130w, 1100w, 890w. 1H-NMR (CDCl3): 3.26 (t, J =
6.9, CH2N3); 3.19 (t, J = 7.0, CH2I); 1.90–1.75 (m, CH2); 1.70–1.55 (m, CH2); 1.40–1.25 (m, 6 CH2).
13C-NMR (CDCl3): 62.8 (t, CH2O); 51.4 (t, CH2N3); 33.5, 30.4, 29.3, 29.2, 28.4, 27.8, 26.6 (8t, 8 CH2);
7.1 (t, CH2I). CI-MS (NH3): 327 (12, [M+18]+), 282 (20, [M+1–N2]+), 154 (100). Anal. Calcd for
C10H20IN3: C, 38.85; H, 6.52; I, 41.04; N, 13.59. Found: C, 39.08; H, 6.37; I, 40.71; N, 13.35.
Alkylations of 1,3-oxazol-5(4H)-one (11) with ω-azidoalkyl iodides (12). General procedure. To a
solution of LDA in a mixture of THF and HMPT between –110 and –60 °C was added a solution of 11 in
THF. After addition of 12, the temperature was increased to 15–20 °C and the mixture stirred for 5–16 h.
Then, the mixture was extracted with cold water (3x) and Et2O, and the organic phase was dried over
MgSO4. Filtration, evaporation, and FCC (SiO2, Et2O/hexane) gave mixtures of 13 and 14.

HETEROCYCLES, Vol. 79, 2009
995
4-(12-Azidododecyl)-4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (13a) and 5-[(12-Azidododecyl)oxy]-
4-benzyl-2-phenyl-1,3-oxazole (14a). From 11 (1.00 g, 3.99 mmol) in THF (7 mL), LDA (4.4 mmol) in
THF (7 mL) and HMPT (4 mL), and 12a (1.50 g, 4.40 mmol) in THF (7 mL). FCC gave 0.44 g (24%) of
13a and 0.57 g (26%) of a ca. 6:11 mixture of 13a and 14a as colorless oils. Data of 13a: IR (CHCl3):
3060w, 3030w, 3010w, 2930s, 2860m, 2100s, 1815s, 1655s, 1605w, 1580w, 1495w, 1465w, 1450m,
1320m, 1290m, 1050m, 970m, 700s. 1H-NMR (CDCl3): 7.90–7.80 (m, 2 arom. H); 7.55–7.50 (m, 1 arom.
H); 7.45–7.40 (m, 2 arom. H); 7.20–7.10 (m, 5 arom. H); 3.30–3.15 (m, CH2N3); 3.22, 3.14 (AB, J = 13.4,
13
PhCH2); 2.05–1.95 (m, CH2); 1.65–1.50 (m, 2 CH2); 1.40–1.10 (m, 8 CH2). C-NMR (CDCl3): 179.6 (s,
CO); 159.6 (s, CN); 134.3 (s, 1 arom. C); 132.3 (d, 1 arom. CH); 130.0, 128.5, 127.9, 127.6 (4d, 2 arom.
CH each); 127.0 (d, 1 arom. CH); 125.7 (s, 1 arom. C); 74.7 (s, C(4)); 51.3 (t, CH2N3); 43.7 (t, PhCH2);
37.3 (t, CH2); 29.3 (t, 5 CH2); 29.1, 29.0, 28.7, 26.6, 23.9 (5t, 5 CH2). CI-MS (NH3): 461 (100, [M+1]+),
433 (26, [M+1–N2]+).
1
Data of 14a (from the mixture): H-NMR (CDCl3): 7.95–7.85 (m, 2 arom. H); 7.30–7.25 (m, 8 arom. H);
4.11 (t, J = 6.6, CH2O); 3.83 (s, PhCH2); 1.80–1.65 (m, CH2).
4-(11-Azidoundecyl)-4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one (13b) and 5-[(11-Azidoundecyl)oxy]-
4-benzyl-2-phenyl-1,3-oxazole (14b). From 11 (0.99 g, 3.94 mmol) in THF (7 mL), LDA (4.1 mmol) in
THF (7 mL) and HMPT (4 mL), and 12b (1.40 g, 4.33 mmol) in THF (7 mL). Yield: 1.14 g (65%) of an
oily 19:1 mixture of 13b and 14b. Data of this mixture: IR (CHCl3): 3060w, 3030w, 3010w, 2930s, 2860s,
2100s, 1815s, 1655s, 1600w, 1580w, 1495m, 1465w, 1450m, 1320m, 1290s, 1255m, 1045m, 1025m,
970m, 895m, 700s. EI-MS: 446 (4, M+.), 418 (5), 355 (12), 285 (100), 251 (32). Anal. Calcd for
C27H34N4O: C, 72.62; H, 7.67; N, 12.55. Found: C, 72.40; H, 7.81; N, 12.81. Data of 13b (from the
mixture): 1H-NMR (CDCl3): 7.90–7.80 (m, 2 arom. H); 7.60–7.50 (m, 1 arom. H); 7.45–7.35 (m, 2 arom.
H); 7.20–7.10 (m, 5 arom. H); 3.24 (t, J = 7.0, CH2N3); 3.22, 3.14 (AB, J = 13.3, PhCH2); 2.05–1.95 (m,
CH2); 1.65–1.50 (m, CH2); 1.45–1.10 (m, 8 CH2). 13C-NMR (CDCl3): 179.6 (s, CO); 159.6 (s, CN); 134.3
(s, 1 arom. C); 132.3 (d, 1 arom. CH); 130.0, 128.5, 127.9, 127.6 (4d, 2 arom. CH each); 127.0 (d, 1 arom.
CH); 125.7 (s, 1 arom. C); 74.7 (s, C(4)); 51.3 (t, CH2N3); 43.7 (t, PhCH2); 37.3 (t, CH2); 29.2 (t, 4 CH2);
29.1, 29.0, 28.7, 26.6, 23.9 (5t, 5 CH2).
Data of 14b (from the mixture): 1H-NMR (CDCl3): 7.95–7.90 (m, 2 arom. H); 7.30–7.25 (m, 8 arom. H);
13
4.11 (t, J = 6.6, CH2O); 3.84 (s, PhCH2); 2.75–2.65 (m, CH2); 2.50–2.35 (m, CH2). C-NMR (CDCl3):
128.0, 127.7, 127.0 (3d, 2 arom. CH each); 38.4 (t, CH2).
4-(10-Azidodecyl)-4-benzyl-2-phenyl-1,3-oxazol-5(4H)-one
(13c)
and
5-[(10-Azidodecyl)oxy]-
4-benzyl-2-phenyl-1,3-oxazole (14c). From 11 (1.00 g, 3.98 mmol) in THF (8 mL) and HMPT (4 mL),
with LDA (4.3 mmol), and 12c (1.40 g, 4.53 mmol) in THF (7 mL). Yield: 1.06 g (61%) of an oily 10:1
mixture of 13c and 14c. Data of this mixture: IR (CHCl3): 3060w, 3030w, 3000w, 2990w, 2930s, 2860m,

996
HETEROCYCLES, Vol. 79, 2009
2100s, 1815s, 1655s, 1600w, 1580w, 1500w, 1470w, 1450m, 1440w, 1320m, 1290m, 1250m, 1045m,
1025m, 980m, 895w, 700s. CI-MS (NH3): 433 (100, [M+1]+), 405 (7), 250 (15). Anal. Calcd for
C26H32N4O: C, 72.19; H, 7.46; N, 12.95. Found: C, 72.38; H, 7.32; N, 12.95. Data of 13c (from the
mixture): 1H-NMR (CDCl3): 7.90–7.80 (m, 2 arom. H); 7.55–7.45 (m, 1 arom. H); 7.45–7.30 (m, 2 arom.
H); 7.15–7.10 (m, 5 arom. H); 3.24 (t, J = 6.9, CH2N3); 3.21, 3.14 (AB, J = 13.5, PhCH2); 2.05–1.90 (m,
CH2); 1.60–1.50 (m, CH2); 1.25–1.20 (m, 7 CH2). 13C-NMR (CDCl3): 179.5 (s, CO); 159.6 (s, CN); 134.3
(s, 1 arom. C); 132.2 (d, 1 arom. CH); 129.9, 128.5, 127.9, 127.5 (4d, 2 arom. CH each); 126.9 (d, 1 arom.
CH); 125.6 (s, 1 arom. C); 74.6 (s, C(4)); 51.2 (t, CH2N3); 43.6 (t, PhCH2); 37.2 (t, CH2); 29.2 (t, CH2);
29.1 (t, 2 CH2), 29.0, 28.8, 28.6, 26.5, 23.8 (5t, 5 CH2).
1
Data of 14c (from the mixture): H-NMR (CDCl3): 7.95–7.90 (m, 2 arom. H); 7.45–7.35 (m, 3 arom. H);
7.35–7.30 (m, 3 arom. H); 7.30–7.05 (m, 2 arom. H); 4.11 (t, J = 6.6, CH2O); 3.84 (s, PhCH2); 2.45–2.35
(m, CH2); 1.75–1.60 (m, 1 H); 1.60–1.45 (m, CH2); 1.45–1.05 (m, 11 H). 13C-NMR (CDCl3): 128.2, 128.1,
127.7, 125.2 (4d, 2 arom. CH each); 74.5 (t, CH2).
Synthesis of N-[ω-azido-1-benzyl-1-(N,N-dimethylcarbamoyl)alkyl]benzamides (15). General procedure.
To a solution of the mixture of 13 and 14 in acetonitrile was added dropwise condensed dimethylamine
and the mixture stirred at rt for 2–5 h. The product was purified by FCC (Et2O/hexane 3:2).
N-[13-Azido-1-benzyl-1-(N,N-dimethylcarbamoyl)tridecyl]benzamide (15a). From 13a/14a (0.50 g, 1.1
mmol) in acetonitrile (5 mL). FCC gave 0.45 g (96%) of 15a as a colorless thick oil. IR (CHCl3): 3360w,
3060w, 3030w, 3000m, 2930s, 2860m, 2100s, 1655s, 1625s, 1605m, 1580w, 1505s, 1480s, 1460m, 1455m,
1400m, 1350w, 1255m, 1150w, 1105w, 1080w, 1055w, 1030w, 880w, 700m. 1H-NMR (CDCl3): 8.00 (br.
s, NH); 7.75–7.65 (m, 2 arom. H); 7.50–7.45 (m, 1 arom. H); 7.45–7.35 (m, 2 arom. H); 7.20–7.15 (m, 3
arom. H); 7.05–6.95 (m, 2 arom. H); 4.13, 3.22 (AB, J = 14.1, PhCH2); 3.50–2.90 (br. s, Me2N); 3.25 (t, J
= 7.0, CH2N3); 3.15–2.90 (m, 1 H); 2.25–1.90 (m, 1 H); 1.65–1.50 (m, 2 CH2); 1.45–1.20 (m, 8 CH2).
13C-NMR (CDCl3): 171.1, 165.7 (2s, 2 CO); 136.5, 135.7 (2s, 2 arom. C); 131.0 (d, 1 arom. CH); 129.4,
129.0, 128.3, 126.7 (4d, 2 arom. CH each); 126.6 (d, 1 arom. CH); 66.2 (s, Cq); 51.3 (t, CH2N3); 38.8 (t,
PhCH2); 38.5 (q, Me2N); 33.7 (t, CH2); 29.4 (t, 6 CH2); 29.0, 28.7, 26.6, 24.3 (4t, 4 CH2). CI-MS (NH3):
506 (100, [M+1]+), 478 (85, [M+1–N2]+), 461 (70). Anal. Calcd for C30H43N5O2: C, 71.25; H, 8.57; N,
13.85. Found: C, 71.08; H, 8.31; N, 13.68.
N-[12-Azido-1-benzyl-1-(N,N-dimethylcarbamoyl)dodecyl]benzamide (15b). From 13b/14b (0.20 g, 0.44
mmol) in acetonitrile (2 mL). FCC gave 0.19 g (94%) of 15b as a colorless thick oil. IR (CHCl3): 3660w,
3240w, 3100w, 3080w, 3060w, 3020w, 3000w, 2930s, 2860s, 2100s, 1655m, 1625s, 1605w, 1580w, 1505s,
1480s, 1470m, 1455m, 1395m, 1350w, 1300w, 1255m, 1210w, 1150w, 1110w, 1080w, 1055w, 1030w,

HETEROCYCLES, Vol. 79, 2009
997
1000w, 880w, 700m. 1H-NMR (CDCl3): 8.01 (br. s, NH); 7.75–7.70 (m, 2 arom. H); 7.50–7.45 (m, 1 arom.
H); 7.45–7.35 (m, 2 arom. H); 7.20–7.15 (m, 3 arom. H); 7.05–7.00 (m, 2 arom. H); 4.14, 3.23 (AB, J =
14.2, PhCH2); 3.60–2.80 (br. s, Me2N); 3.25 (t, J = 6.9, CH2N3); 3.10–2.95 (m, 1 H); 2.05–1.90 (m, 1 H);
1.50–1.20 (m, 9 CH2). 13C-NMR (CDCl3): 171.1, 165.6 (2s, 2 CO); 136.5, 135.7 (2s, 2 arom. C); 130.9 (d,
1 arom. CH); 129.4, 128.3, 127.9, 126.7 (4d, 2 arom. CH each); 126.6 (d, 1 arom. CH); 66.1 (s, Cq); 51.3
(t, CH2N3); 38.7 (t, PhCH2); 38.4 (q, Me2N); 33.6, 29.3 (2t, 2 CH2); 29.2 (t, 4 CH2); 28.9, 28.6, 26.5, 24.2
(4t, 4 CH2). CI-MS (NH3): 492 (8, [M+1]+), 464 (8, [M+1–N2]+), 447 (100), 419 (5). Anal. Calcd for
C29H41N5O2: C, 70.84; H, 8.41; N, 14.24. Found: C, 71.01; H, 8.20; N, 14.43.
N-[11-Azido-1-benzyl-1-(N,N-dimethylcarbamoyl)undecyl]benzamide (15c). From 13c/14c (0.84 g, 1.94
mmol) in acetonitrile (10 mL). FCC gave 0.76 g (91%) of 15c as a colorless thick oil. IR (CHCl3): 3660w,
3355m, 3060w, 3030w, 3000m, 2930s, 2860m, 2100s, 1655s, 1625s, 1605m, 1580m, 1505s, 1480s, 1455m,
1
1400s, 1350w, 1300w, 1255m, 1180w, 1115m, 1080w, 1055w, 1030w, 1000w, 880w, 700m. H-NMR
(CDCl3): 8.00 (br. s, NH); 7.75–7.70 (m, 2 arom. H); 7.50–7.40 (m, 1 arom. H); 7.40–7.30 (m, 2 arom.
H); 7.20–7.10 (m, 3 arom. H); 7.00–6.90 (m, 2 arom. H); 4.12, 3.22 (AB, J = 14.0, PhCH2); 3.50–2.85 (br.
s, Me2N); 3.24 (t, J = 7.0, CH2N3); 3.10–2.90 (m, 1 H); 2.00–1.85 (m, 1 H); 1.60–1.50 (m, CH2);
1.50–1.20 (m, 7 CH2). 13C-NMR (CDCl3): 170.9, 165.6 (2s, 2 CO); 136.4, 135.5 (2s, 2 arom. C); 130.9 (d,
1 arom. CH); 129.4, 128.2, 127.8, 126.6 (4d, 2 arom. CH each); 126.4 (d, 1 arom. CH); 65.8 (s, Cq); 51.1
(t, CH2N3); 38.5 (t, PhCH2); 38.3 (q, Me2N); 33.4, 29.2 (2t, 2 CH2); 29.1 (t, 3 CH2); 28.8, 28.5, 26.4, 24.1
(4t, 4 CH2). CI-MS (NH3): 450 (8, [M+1–N2]+), 433 (100), 405 (5). Anal. Calcd for C28H39N5O2: C, 70.41;
H, 8.23; N, 14.66. Found: C, 70.63; H, 8.20; N, 14.44.
Synthesis of N-[ω-amino-1-benzyl-1-(N,N-dimethylcarbamoyl)alkyl]benzamides (16). General procedure.
To a solution of 15 (1 equiv.) in THF under N2 atmosphere at rt was added Et3P (1.4 equiv.) and the
mixture stirred at rt for 2.5 h. The spontaneous elimination of N2 ceased after ca. 20 min. After addition
of water (2.8 equiv.) and stirring for 2 h, the mixture was poured into CHCl3/MeOH/NH3 (85:14:1),
filtered through SiO2, and evaporated. The product contained traces of Et3PO, which could not be
removed.
N-[13-Amino-1-benzyl-1-(N,N-dimethylcarbamoyl)tridecyl]benzamide (16a). From 15a (0.35 g, 0.69
mmol), Et3P (0.14 mL, 0.97 mmol), and H2O (0.035 g, 1.94 mmol). Yield: 0.33 g (95%) of 16a as a
colorless thick oil. IR (CHCl3): 3620w (br), 3360w (br), 3060w, 3030w, 3000m, 2930s, 2860m, 1660m,
1625s, 1605m, 1580w, 1505s, 1480s, 1455m, 1400m, 1250w, 1220w, 1180w, 1150w, 1110m, 1080w,
1050w, 1030w, 880w, 700m. 1H-NMR (CDCl3): 7.99 (br. s, NH); 7.75–7.65 (m, 2 arom. H); 7.50–7.45 (m,
1 arom. H); 7.45–7.35 (m, 2 arom. H); 7.20–7.15 (m, 3 arom. H); 7.05–6.95 (m, 2 arom. H); 4.12, 3.22

998
HETEROCYCLES, Vol. 79, 2009
(AB, J = 14.2, PhCH2); 3.60–2.80 (br. s, Me2N); 3.05–2.95 (m, 1 H); 2.67 (t, J = 7.0, CH2N); 2.00–1.90 (m,
13
1 H); 1.35–1.15 (m, 10 CH2). C-NMR (CDCl3): 170.8, 165.6 (2s, 2 CO); 136.3, 135.2 (2s, 2 arom. C);
130.8 (d, 1 arom. CH); 129.4, 128.1, 127.7, 126.5 (4d, 2 arom. CH each); 126.3 (d, 1 arom. CH); 65.4 (s,
Cq); 41.1 (t, CH2N); 38.2 (t, PhCH2); 38.1 (q, Me2N); 33.2 (t, CH2); 29.1 (t, 5 CH2); 29.0 (t, 2 CH2); 26.4,
23.9, 18.6 (3t, 3 CH2). ESI-MS (MeOH): 480 (100, [M+1]+).
N-[12-Amino-1-benzyl-1-(N,N-dimethylcarbamoyl)dodecyl]benzamide (16b). From 15b (0.24 g, 0.49
mmol), Et3P (0.11 mL, 0.75 mmol), and H2O (0.025 g, 1.40 mmol). Yield: 0.23 g (quant.) of 16b as a
colorless thick oil. IR (CHCl3): 3360m (br), 3070w, 3030w, 3000m, 2930s, 2860m, 1660s, 1625s, 1605m,
1580m, 1505s, 1480s, 1455m, 1400m, 1255w, 1180w, 1150w, 1110w, 1080w, 1050w, 1030w, 880w, 705m.
1H-NMR (CDCl3): 7.99 (br. s, NH); 7.75–7.70 (m, 2 arom. H); 7.50–7.35 (m, 2 arom. H); 7.20–7.15 (m, 3
arom. H); 7.05–6.95 (m, 3 arom. H); 4.12, 3.22 (AB, J = 14.1, PhCH2); 3.19 (br. s, Me2N); 3.05–2.90 (m,
1 H); 2.70 (t, J = 6.4, CH2N); 2.05–1.80 (m, 1 H); 1.95 (br. s, NH2); 1.50–1.40 (m, CH2); 1.40–1.00 (m, 8
13
CH2). C-NMR (CDCl3): 171.1, 165.7 (2s, 2 CO); 136.5, 135.6 (2s, 2 arom. C); 131.0 (d, 1 arom. CH);
129.5, 128.3, 128.0, 126.7 (4d, 2 arom. CH each); 126.6 (d, 1 arom. CH); 66.1 (s, Cq); 41.7 (t, CH2N);
38.7 (t, PhCH2); 38.5 (q, Me2N); 33.7, 32.7 (2t, 2 CH2); 29.4 (t, 2 CH2); 29.34 (t, 2 CH2); 29.30 (t, 2 CH2);
26.7, 24.2 (2t, 2 CH2). CI-MS (i-butane): 466 (100, [M+1]+).
N-[11-Amino-1-benzyl-1-(N,N-dimethylcarbamoyl)undecyl]benzamide (16c). From 15c (0.57 g, 1.19
mmol), Et3P (0.27 mL, 1.83 mmol), and H2O (0.13 g, 7.22 mmol). Yield: 0.52 g (97%) of 16c as a
colorless thick oil. IR (CHCl3): 3360m, 3060w, 3000m, 2930s, 2860m, 1660s, 1625s, 1610m, 1580m,
1510s, 1480s, 1460m, 1400m, 1255w, 1215w, 1150m, 1110m, 1080w, 1055w, 1030w, 880w, 700m.
1H-NMR (CDCl3): 7.99 (br. s, NH); 7.70–7.65 (m, 2 arom. H); 7.50–7.45 (m, 1 arom. H); 7.45–7.35 (m, 2
arom. H); 7.20–7.15 (m, 3 arom. H); 7.05–6.95 (m, 2 arom. H); 4.12, 3.22 (AB, J = 14.2, PhCH2); 3.19 (br.
s, Me2N); 3.10–2.95 (m, 1 H); 2.65 (t, J = 6.9, CH2N); 2.05–1.90 (m, 1 H); 1.60–1.10 (m, 8 CH2).
13C-NMR (CDCl3): 171.0, 165.6 (2s, 2 CO); 136.5, 135.6 (2s, 2 arom. C); 130.9 (d, 1 arom. CH); 129.4,
128.3, 127.9, 126.6 (4d, 2 arom. CH each); 126.5 (d, 1 arom. CH); 66.1 (s, Cq); 42.0 (t, CH2N); 38.7 (t,
PhCH2); 38.4 (q, Me2N); 33.6 (t, CH2); 29.3 (t, 3 CH2); 29.2 (t, 3 CH2); 26.7, 24.2 (2t, 2 CH2). CI-MS
(NH3): 452 (100, [M+1]+).
HCl catalyzed cyclization reactions with 16. General procedure. Through a 1.9 mM solution of 16 in
boiling toluene, dry HCl gas was bubbled for 1.5–2 h, and the boiling mixture stirred for 15 h.
Evaporation of the solvent and FCC (Et2O/hexane 1:1) gave the lactam (18).
N-(3-Benzyl-2-oxo-1-azacyclopentadec-3-yl)benzamide (18a). From 16a (0.20 g, 0.42 mmol) in toluene
(373 mL). Yield: 0.048 g (27%) of 18a. Colorless solid, mp 257.7–265.8 °C (decomp.). Crystals suitable

HETEROCYCLES, Vol. 79, 2009
999
for an X-ray crystal-structure determination were obtained from Et2O/hexane/CH2Cl2. IR (CHCl3): 3620w
(br), 3450w, 3380w, 3100w, 3060w, 3030w, 3010w, 2940s, 2880w, 2860m, 1675m, 1650s, 1605w, 1580w,
1510w, 1485s, 1465m, 1455m, 1265m, 1230w, 1215w, 1205w, 1125m (br), 1050w, 1030w, 880w, 715m,
1
705m. H-NMR (CDCl3): 7.75–7.70 (m, 2 arom. H); 7.63 (s, NH); 7.50–7.45 (m, 1 arom. H); 7.45–7.35
(m, 2 arom. H); 7.20–7.15 (m, 3 arom. H); 7.10–7.00 (m, 2 arom. H); 5.80–5.30 (m, CH2NH); 3.85, 3.10
(AB, J = 13.8, PhCH2); 3.85–3.70 (m, 1 H of CH2N); 3.20–2.95 (m, 1 H of CH2N + 1 H); 1.80–1.00 (m, 21
13
H). C-NMR (CDCl3): 172.5, 166.5 (2s, 2 CO); 136.1, 135.4 (2s, 2 arom. C); 131.3 (d, 1 arom. CH);
129.8, 128.5, 128.2 (3d, 2 arom. CH each); 126.9 (d, 3 arom. CH); 67.4 (s, Cq); 65.3 (t, CH2N); 41.9 (t,
PhCH2); 39.7, 36.4, 29.7, 27.2, 27.0, 26.7, 26.4, 26.2, 25.8, 24.9, 23.2 (11t, 11 CH2). ESI-MS (MeOH):
480 (100, [M+2 Na]+), 466 (5, [M+MeOH]+), 435 (8, [M+1]+).
N-(3-Benzyl-2-oxo-1-azacyclotetradec-3-yl)benzamide (18b). From 16b (0.07 g, 0.15 mmol) in toluene
(100 mL). Yield: 0.019 g (30%) of pure 18b (and 0.025 g of a mixture of 18b and Me2NH2Cl). Colorless
solid, mp 267.0–268.0 °C (decomp.). Crystals suitable for an X-ray crystal-structure determination were
obtained from hexane/CH2Cl2. IR (CHCl3): 3450w, 3370w, 3000w, 2995w, 2935s, 2860m, 1670m, 1650s,
1605w, 1580w, 1510s, 1485s, 1460m, 1445w, 1365w, 1355w, 1130w, 1030w, 910w, 880w, 700m.
1H-NMR (CDCl3): 7.75–7.70 (m, 2 arom. H); 7.64 (br. s, NH); 7.50–7.35 (m, 3 arom. H); 7.25–7.15 (m, 3
arom. H); 7.10–7.05 (m, 2 arom. H); 5.91 (br t, CH2NH); 3.90, 3.09 (AB, J = 13.8, PhCH2); 3.75–3.65
13
(m, 1 H of CH2N); 3.15–2.95 (m, 1 H of CH2N + 1 H); 1.80–1.05 (m, 19 H). C-NMR (CDCl3): 172.4,
166.3 (2s, 2 CO); 136.0, 135.4 (2s, 2 arom. C); 131.2 (d, 1 arom. CH); 129.7, 128.4, 128.0 (3d, 2 arom.
CH each); 126.8 (d, 3 arom. CH); 65.2 (s, Cq); 61.8 (t, CH2N); 39.3 (t, PhCH2); 36.2, 27.8, 26.0, 25.9,
25.7, 25.0, 23.2, 23.0, 22.9, 21.2 (10t, 10 CH2). CI-MS (i-butane): 421 (100, [M+1]+).
N-(3-Benzyl-2-oxo-1-azacyclotridec-3-yl)benzamide (18c). From 16c (0.33 g, 0.80 mmol) in toluene (300
mL). Yield: 0.034 g (11%) of 18c. Colorless solid, mp 250.0–251.0 °C (decomp.). IR (CHCl3): 3440w,
3360w, 3050w, 2995w, 2920s, 2850m, 1670m, 1645s, 1600w, 1575w, 1510s, 1480s, 1460m, 1440m,
1
1340w, 1320w, 1290w, 1260w, 1140w, 1115m, 880w, 700m. H-NMR (CDCl3): 7.75–7.70 (m, 2 arom.
H); 7.61 (br. s, NH); 7.50–7.45 (m, 1 arom. H); 7.45–7.35 (m, 2 arom. H); 7.20–7.10 (m, 3 arom. H);
7.10–7.05 (m, 2 arom. H); 5.79 (br d, CH2NH); 3.90, 3.10 (AB, J = 13.9, PhCH2); 3.80–3.70 (m, 1 H of
CH2N); 3.20–2.95 (m, 1 H of CH2N + 1 H); 1.85–1.70 (m, 1H); 1.70–1.15 (m, 16 H). CI-MS (i-butane):
407 (100, [M+1]+).
12-Amino-2-benzamido-2-benzyldodecanoic acid (19c). An analogous experiment with 16c in non-dried
toluene gave 51% of 19c. Colorless solid, mp 144.0–145.0 °C (decomp.). IR (KBr): 3680–2340s (br),
3420m, 3350m, 3050m, 2920s, 2850s, 1660s, 1640s, 1630s, 1600s, 1570s, 1510s, 1475s, 1455s, 1440s,
1
1385s, 1325m, 1310m, 1180w, 1115w, 1070w, 1030w, 1000w, 875w, 700s. H-NMR (CDCl3): 7.74 (s,
NH); 7.65–7.55 (m, 2 arom. H); 7.45–7.30 (m, 3 arom. H); 7.15–7.05 (m, 5 arom. H); 3.71, 3.10 (AB, J =

1000
HETEROCYCLES, Vol. 79, 2009
13.1, PhCH2); 3.60–3.00 (m, NH2); 2.76 (t-like, J ≈ 7.6, CH2N); 2.65–2.60 (m, 1 H); 1.95–1.80 (m, 1H);
13
1.75–1.05 (m, 8 CH2). C-NMR (CD3OD): 178.5, 168.5 (2s, 2 CO); 139.5, 137.1 (2s, 2 arom. C); 132.3
(d, 1 arom. CH); 130.9, 129.6, 128.7, 127.5 (4d, 2 arom. CH each); 127.1 (d, 1 arom. CH); 68.5 (s, Cq);
42.1 (t, CH2N); 40.6 (t, PhCH2); 36.9, 30.5, 30.3 (3t, 3 CH2); 30.1 (t, 2 CH2); 30.0, 28.4, 27.3, 25.6 (4t, 4
CH2). ESI-MS (MeOH): 463 (18, [M+K]+), 447 (100, [M+Na]+), 425 (35, [M+1]+).
BF3 catalyzed reactions with 16a. To a solution of 16a (0.15 g, 0.31 mmol) in toluene (60 mL) at 100 °C,
BF3.Et2O (0.47 mmol) in CH2Cl2 was added and the mixture stirred for 19 h. Evaporation of the solvent
and FCC (Et2O/hexane 1:1 and then CHCl3/MeOH/NH3 85:14:1) gave lactam (18a) (0.009 g, 7%), an
unstable product (20a) (0.013 g, 10%), azlactone (17a) (0.040 g, 30%), and the acid (21a) (0.049 g, 35%).
The unstable 20a converted into 17a.
4-(12-Aminododecyl-4-benzyl-1,3-oxazol-5(4H)-one (17a). Colorless oil. IR (CHCl3): 3650w, 3580w,
3360w, 3260w, 3020m, 2920s, 2850m, 1810m, 1655s, 1600w, 1580w, 1510m, 1490m, 1480m, 1450m,
1
1320m, 1290m, 1240w, 1130m (br), 1065s, 1040s, 1020s, 970m, 930m, 910m, 700s. H-NMR (CDCl3):
7.85–7.80 (m, 2 arom. H); 7.60–7.50 (m, 1 arom. H); 7.50–7.35 (m, 2 arom. H); 7.15–7.05 (m, 5 arom.
H); 3.90–3.80 (m, NH2); 3.21, 3.14 (AB, J = 13.4, PhCH2); 3.00–2.85 (m, 2 H); 2.05–1.95 (m, 2 H);
1.75–1.55 (m, 5 H); 1.40–1.10 (m, 15 H). CI-MS (NH3): 435 (100, [M+1]+).
2-Amino-14-benzamido-2-benzyltetradecanoic acid (21a). Colorless solid, mp 121.7–122.2 °C. IR
(CHCl3): 3700–3210m, 3210–2200s, 3110m, 3050m, 3020m, 2920s, 2840s, 1650m, 1640s, 1630s, 1575s,
1510s, 1480s, 1465s, 1450m, 1440m, 1385s, 1325w, 1310w, 1180w, 1115w, 1075w, 1025w, 1000w, 875w,
1
700m. H-NMR (CDCl3): 7.66 (s, NH); 7.55–7.50 (m, 2 arom. H); 7.40–7.35 (m, 1 arom. H); 7.35–7.25
(m, 2 arom. H); 7.10–7.00 (m, 5 arom. H); 3.70, 3.09 (AB, J = 13.1, PhCH2); 3.30–3.25 (m, 1 H);
2.80–2.75 (m, 2 H); 2.55–2.50 (m, 1 H); 1.90–1.50 (m, 2H); 1.40–1.00 (m, 18 H). CI-MS (NH3): 453 (100,
[M+1]+), 435 (11, [M–H2O]+), 409 (100, [M–CO2]+).
Methyl 2-amino-14-benzamido-2-benzyltetradecanoate (22a). In an analogous experiment, a solution of
16a (0.15 g, 0.31 mmol) in toluene (62 mL) and BF3.Et2O (0.47 mmol) in CH2Cl2 at 90 °C was stirred for
2 h. Then, MeOH (0.06 g, 1.88 mmol) was added and the mixture heated to reflux for 21 h. Evaporation
of the solvent and FCC (CHCl3/MeOH/NH3 85:14:1) gave 0.116 g (80%) of 22a. Colorless thick oil. IR
(CHCl3): 3400m (br), 3050w, 2980m, 2920s, 2850s, 1730m, 1660s, 1600w, 1580w, 1515s, 1485s, 1450m,
1370w, 1350m, 1240m, 1180m, 1170–1090s, 1070s, 1025s, 880w, 700m. 1H-NMR (CDCl3): 7.70–7.65 (m,
2 arom. H); 7.55–7.45 (m, 1 arom. H); 7.45–7.35 (m, 2 arom. H); 7.20–7.15 (m, 3 arom. H); 7.05–6.95 (m,
2 arom. H); 6.96 (s, NH); 4.10–3.70 (m, NH2); 3.91, 3.16 (AB, J = 13.5, PhCH2); 3.82 (s, MeO); 2.92 (t, J
= 7.7, CH2N); 2.85–2.70 (m, 1 H); 2.00–1.85 (m, 1 H); 1.65–1.55 (m, CH2); 1.40–1.10 (m, 9 CH2).
13C-NMR (CDCl3): 173.9, 166.7 (2s, 2 CO); 136.3, 135.1 (2s, 2 arom. C); 131.4 (d, 1 arom. CH); 129.5,

HETEROCYCLES, Vol. 79, 2009
1001
128.5, 128.1, 126.6 (4d, 2 arom. CH each); 126.7 (d, 1 arom. CH); 66.4 (s, Cq); 52.6 (q, MeO); 40.64,
40.60, 40.4, 35.1 (4t, 4 CH2); 29.4 (t, 3 CH2); 29.2 (t, 2 CH2); 29.0, 28.9, 26.3, 24.2 (4t, 4 CH2). CI-MS
(NH3): 481 (5, [M+NH4]+), 467 (100, [M+1]+).
BF3 catalyzed reaction with 16c. To a solution of 16c (0.137 g, 0.30 mmol) in toluene (150 mL) at 100 °C,
BF3.Et2O (0.30 mmol) in CH2Cl2 was added and the mixture stirred for 13 h. Then, additional BF3.Et2O
(0.30 mmol) was added, the mixture stirred at 100 °C for 7.5 h, diisopropyl(ethyl)amine (2 x 30 mmol)
added, and the boiling mixture stirred for 13 h. Evaporation of the solvent and FCC (Et2O/hexane 1:1 and
then CHCl3/MeOH/NH3 85:14:1) gave the lactam (18c) (0.010 g, 8%) and a less stable product (20c)
(0.028 g, 23%).
13-Benzyl-1-phenyl-15-oxa-2,16-diazabicyclo[12.2.1]octadecan-14-one (20c). Colorless oil, which
slowly decomposed at rt. IR (CHCl3): 3660w, 3580w, 3350w, 3300w (br), 3010w, 2920s, 2850m, 1810s,
1650s, 1575w, 1490w, 1460w, 1450m, 1390w, 1320m, 1290m, 1225w, 1205w, 1130s (br), 1040m, 970s
(br), 890w, 695s. 1H-NMR (CDCl3): 7.85–7.80 (m, 2 arom. H); 7.60–7.45 (m, 1 arom. H); 7.45–7.35 (m, 2
arom. H); 7.20–7.10 (m, 5 arom. H); 7.10–6.60 (m, NH); 4.15–4.10 (m, NH); 3.20, 3.12 (AB, J = 13.3,
13
PhCH2); 3.00–2.85 (m, CH2); 2.05–1.95 (m, CH2); 1.70–1.55 (m, CH2); 1.30–1.10 (m, 7 CH2). C-NMR
(CD3OD): 179.9 (s, CO); 134.4 (s, 1 arom. C); 132.5 (d, 1 arom. CH); 130.1, 128.7, 128.1, 127.7 (4d, 2
arom. CH each); 127.1 (d, 1 arom. CH); 125.7 (s, 1 arom. C); 94.2 (s, NCN); 74.9 (s, NCq); 43.8 (t,
CH2N); 41.5 (t, PhCH2); 40.3, 37.4 (2t, 2 CH2); 29.3 (t, 3 CH2); 27.4, 26.3, 24.0, 19.0 (4t, 4 CH2). CI-MS
(NH3): 407 (100, [M+1]+).
X-Ray Crystal-Structure Determination of 18a and 18b (Figure 1).63 All measurements were made on a
Rigaku AFC5R diffractometer using graphite-monochromated MoK radiation (λ = 0.71073 Å) and a
α
12kW rotating anode generator. The intensities were corrected for Lorentz and polarization effects, but not
for absorption. Equivalent reflections were merged. Data collection and refinement parameters are given
below, and views of the molecules are shown in Figure 1. The structures of 18a and 18b were solved by
direct methods using SHELXS86,64 respectively, which revealed the positions of all non-hydrogen atoms.
In both cases, the macrocyclic ring is disordered and two sets of positions were defined for five and seven
consecutive CH2 groups, respectively. The site occupation factor of the major conformation of these
groups refined to 0.662(4) and 0.667(5), respectively. Similarity restraints were applied to the chemically
equivalent bond lengths and angles involving all disordered C-atoms, while neighboring atoms within and
between each disordered conformation were restrained to have similar atomic displacement parameters.
The non-hydrogen atoms were refined anisotropically. The amide H-atoms were placed in the positions
indicated by difference electron density maps and their positions were allowed to refine together with

1002
HETEROCYCLES, Vol. 79, 2009
individual isotropic displacement parameters. All remaining H-atoms were placed in geometrically
calculated positions and refined by using a riding model where each H-atom was assigned a fixed
isotropic displacement parameter with a value equal to 1.2Ueq of its parent C-atom. The refinement of each
structure was carried out on F2 by using full-matrix least-squares procedures, which minimized the
function Σw(Fo2–Fc2)2. Corrections for secondary extinction were not applied. Neutral atom scattering
factors for non-H-atoms were taken from ref.65, and the scattering factors for H-atoms were taken from
ref.66 Anomalous dispersion effects were included in F ;67 the values for ƒ’ and ƒ” were those of ref.68 The
c
values of the mass attenuation coefficients are those of ref.69 All calculations were performed using the
SHELXL97 program.70 Crystal data for 18a: Crystallized from Et2O/hexane/CH2Cl2, C28H38N2O2, M =
434.60, colorless, prism, crystal dimensions 0.18 × 0.23 × 0.40 mm, monoclinic, space group C2/c, Z = 8,
reflections for cell determination 23, 2θ range for cell determination 21–37°, a = 26.026(5) Å, b =
10.833(3) Å, c = 21.330(4) Å, β = 119.83(1)°, V = 5217(2) Å3, DX = 1.107 g⋅cm–3, µ(MoKα) = 0.069 mm–1,
T = 295 K, ω scans, 2θmax = 55°, total reflections measured 6444, symmetry independent reflections 5989,
reflections with I > 2σ(I) 2327, reflections used in refinement 5989, parameters refined 370, restraints 223,
final R (on F; I > 2σ(I) reflections) = 0.0751, wR = 0.2682 (w = [σ2(Fo2) + (0.1293P)2]–1 where P = (Fo2 +
2Fc2)/3, goodness of fit 1.006, final Δmax/σ = 0.002, Δρ (max; min) = 0.33; –0.33 e Å–3.
Crystal data for 18b: Crystallized from CH2Cl2/hexane, C27H36N2O2, M = 420.58, colorless, plate, crystal
dimensions 0.10 × 0.35 × 0.47 mm, monoclinic, space group C2/c, Z = 8, reflections for cell determination
23, 2θ range for cell determination 24–45°, a = 24.951(3) Å, b = 10.683(4) Å, c = 20.996(2) Å, β =
118.377(7)°, V = 4924(2) Å3, DX = 1.135 g⋅cm–3, µ(MoKα) = 0.071 mm–1, T = 173(1) K, ω/2θ scans, 2θmax
= 55°, total reflections measured 6134, symmetry independent reflections 5692, reflections with I > 2σ(I)
3655, reflections used in refinement 5692, parameters refined 335, restraints 117, final R (on F; I > 2σ(I)
2
reflections) = 0.0485, wR = 0.1419 (w = [σ2(Fo2) + (0.0637P)2 + 1.4002P]–1 where P = (Fo + 2Fc2)/3,
goodness of fit 1.021, final Δmax/σ = 0.001, Δρ (max; min) = 0.35; –0.21 e Å–3.
ACKNOWLEDGEMENTS
We thank the analytical services of our institute for analyses and spectra. Financial support by the Swiss
National Science Foundation and F. Hoffmann-La Roche AG, Basel, is gratefully acknowledged.
REFERENCES AND NOTES
1. Part of the Ph.D. thesis of S.P.F., University of Zürich, 1995; present address: Carbogen Amcis AG,
Schachenallee 29, CH-5001 Aarau, Switzerland.

HETEROCYCLES, Vol. 79, 2009
1003
2. A. Budzowski, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2008, 91, 1471.
3. T. Jeremic, A. Linden, and H. Heimgartner, J. Pept. Sci., 2008, 14, 1051.
4. K. A. Brun, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2008, 91, 526.
5. J. L. Räber, K. A. Brun, and H. Heimgartner, Heterocycles, 2007, 74, 397.
6. W. Altherr, A. Linden, and H. Heimgartner, Chem. Biodivers., 2000, 4, 1144.
7. S. Stamm and H. Heimgartner, Helv. Chim. Acta, 2006, 89, 1841.
8. S. Stamm and H. Heimgartner, Tetrahedron, 2006, 62, 9671.
9. P. Köttgen, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2006, 89, 731.
10. S. Stamm, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2006, 89, 1.
11. N. Pradeille, O. Zerbe, K. Moehle, A. Linden, and H. Heimgartner, Chem. Biodivers., 2005, 2, 1127.
12. T. Jeremic, A. Linden, K. Moehle, and H. Heimgartner, Tetrahedron, 2005, 61, 1871.
13. T. Jeremic, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2004, 87, 3056.
14. T. Jeremic, A. Linden, and H. Heimgartner, Chem. Biodivers., 2004, 1, 1730.
15. S. Stamm and H. Heimgartner, Eur. J. Org. Chem., 2004, 3820.
16. R. T. N. Luykx, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2003, 86, 4093.
17. H. Heimgartner, Angew. Chem., Int. Ed. Engl., 1991, 30, 238.
18. P. Wipf and H. Heimgartner, Helv. Chim. Acta, 1990, 73, 13.
19. M. Sahebi, P. Wipf, and H. Heimgartner, Tetrahedron, 1989, 45, 2999.
20. P. Wipf and H. Heimgartner, Helv. Chim. Acta, 1987, 70, 354.
21. D. Obrecht and H. Heimgartner, Helv. Chim. Acta, 1987, 70, 102.
22. P. Wipf and H. Heimgartner, Helv. Chim. Acta, 1986, 69, 1153.
23. D. Obrecht and H. Heimgartner, Helv. Chim. Acta, 1981, 64, 482.
24. D. Obrecht and H. Heimgartner, Chimia, 1982, 36, 7.
25. C. Theis, T. Degenkolb, and H. Brückner, Chem. Biodivers., 2008, 5, 2337.
26. K. N. Koch, A. Linden, and H. Heimgartner, Tetrahedron, 2001, 57, 2311.
27. K. N. Koch, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2000, 83, 1881.
28. K. N. Koch, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2000, 83, 233.
29. B. Iliev, A. Linden, R. Kunz, and H. Heimgartner, Tetrahedron, 2006, 62, 1079.
30. B. Iliev, A. Linden, and H. Heimgartner, Helv. Chim. Acta, 2003, 86, 3215.
31. H. Heimgartner, F. S. Arnhold, S. P. Fritschi, K. N. Koch, J. E. F. Magirius, and A. Linden, J.
Heterocycl. Chem., 1999, 36, 1539.
32. R. Filler, Adv. Heterocycl. Chem., 1965, 4, 75.
33. W. Steglich, Fortschr. Chem. Forsch., 1969, 12, 77.
34. R. Filler and Y. S. Rao, Adv. Heterocycl. Chem., 1977, 21, 175.

1004
HETEROCYCLES, Vol. 79, 2009
35. A. K. Mukerjee and P. Kumar, Heterocycles, 1981, 16, 1995.
36. A. K. Mukerjee, Heterocycles, 1987, 26, 1077.
37. U. Wittmann, F. Tranel, R. Froehlich, and G. Haufe, Synthesis, 2006, 2085.
38. B. M. Trost and C. Lee, J. Am. Chem. Soc., 2001, 123, 12191.
39. N. Devi, M. D. Threadgill, and S. J. B. Tendler, Synth. Commun., 1988, 18, 1545.
40. D. Obrecht, B. Scholl, and H. Heimgartner, Helv. Chim. Acta, 1985, 68, 465.
41. R. Lohmar and W. Steglich, Chem. Ber., 1980, 113, 3706.
42. W. Steglich, V. Austel, and A. Prox, Angew. Chem., Int. Ed. Engl., 1968, 7, 726.
43. M. Sedlak, R. Keder, P. Skala, and J. Hanusek, J. Phys. Org. Chem., 2005, 18, 743.
44. M. Altamura, R.-M. Catalioto, D. Giannotti, A. Giolitti, S. Guliani, A. Guidi, N. J. S. Harmat, A.
Lecci, S. Meini, R. Nannicini, F. Pasqui, M. Tramontana, A. Triolo, and C. A. Maggi, J. Med. Chem.,
2007, 50, 4793.
45. D. Obrecht, C. Spiegler, P. Schönholzer, K. Müller, H. Heimgartner, and F. Stierli, Helv. Chim. Acta,
1992, 75, 1666.
46. D. Obrecht and H. Heimgartner, Tetrahedron Lett., 1984, 25, 1717.
47. F. M. F. Chen, K. Kuroda, and N. L. Benoiton, Synthesis, 1979, 230.
48. D. F. DeTar, R. Silverstein, and F. F. Rogers Jr., J. Am. Chem. Soc., 1966, 88, 1024.
49. S. Götze, B. Kübel, and W. Steglich, Chem. Ber., 1976, 109, 2331.
50. B. Kübel, P. Gruber, R. Hurnhaus, and W. Steglich, Chem. Ber., 1979, 112, 128.
51. D. Obrecht, U. Bohdal, R. Ruffieux, and K. Müller, Helv. Chim. Acta, 1994, 77, 1423.
52. M. L. Gelmi, D. Pocar, and L. M. Rossi, Synthesis, 1984, 763.
53. K. Hojo, S. Kobayashi, K. Soai, S. Ikedea, and T. Mukaiyama, Chem. Lett., 1977, 635.
54. H. Staudinger and J. Meier, Helv. Chim. Acta, 1919, 2, 635.
55. N. Knouzi, M. Vaultier, and R. Carrié, Bull. Soc. Chim. Fr., 1985, 815.
56. W. Q. Tian and Y. A. Wang, J. Org. Chem., 2004, 69, 4299.
57. No reaction occurred by treatment of 15b with Ph3P under the conditions of ref.55, whereas with
Bu3P a slow evolution of gas was observed.
58. In the case of 15b, small amounts (<5%) of the corresponding lactam 18b were obtained, when the
reaction mixture was dissolved in toluene and heated under reflux (neutral conditions).
59. W. C. Still, M. Kahn, and A. Mitra, J. Org. Chem., 1978, 43, 2923.
60. C. K. Johnson, ORTEPII, Report ORNL-5138; Oak Ridge National Laboratory, Oak Ridge,
Tennessee, 1976.
61. J. Bernstein, R. E. Davis, L. Shimoni, and N.-L. Chang, Angew. Chem., Int. Ed. Engl., 1995, 34,
1555.

HETEROCYCLES, Vol. 79, 2009
1005
62. We believe that in the corresponding 4-(ω-hydroxyalkyl)-1,3-oxazol-5(4H)-ones the oxazoline
N-atom is the preferred site for protonation.
63. CCDC-706638 and 706639 contain the supplementary crystallographic data for this paper. These
data can be obtained free of charge from the Cambridge Crystallographic Data Centre via
www.ccdc.cam.ac.uk/data_request/cif.
64. G. M. Sheldrick, SHELXS86, Acta Crystallogr., Sect. A, 1990, 46, 467.
65. E. N. Maslen, A. G. Fox, and M. A. O'Keefe, in ‘International Tables for Crystallography’, ed. by A.
J. C. Wilson, Kluwer Academic Publishers, Dordrecht, 1992, Vol. C, Table 6.1.1.1, p. 477.
66. R. F. Stewart, E. R. Davidson, and W. T. Simpson, J. Chem. Phys. 1965, 42, 3175.
67. J. A. Ibers and W. C. Hamilton, Acta Crystallogr. 1964, 17, 781.
68. D. C. Creagh and W. J. McAuley, in ‘International Tables for Crystallography’, ed. by A. J. Wilson,
Kluwer Academic Publishers, Dordrecht, 1992, Vol. C, Table 4.2.6.8, pp. 219–222.
69. D. C. Creagh and J. H. Hubbell, in ‘International Tables for Crystallography’, ed. by A. J. C. Wilson,
Kluwer Academic Publishers, Dordrecht, 1992, Vol. C, Table 4.2.4.3, pp. 200–206.
70. G. M. Sheldrick, SHELXL79, Program for the Refinement of Crystal Structures, University of
Göttingen, Germany, 1997.